ArticleGut and liver2025

Optimizing Infliximab Use in Real-World Inflammatory Bowel Disease: Insights from a Population Pharmacokinetic Model Integrating Intravenous and Subcutaneous Formulations.

Sung Hoon Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.